Chandra Bhagat Pharma Limited (BOM:542934)

Market Cap	296.97M -28.4%
Revenue (ttm)	1.16B +31.0%
Net Income	30.46M +255.1%
EPS	4.04 +255.3%
Shares Out	7.55M
PE Ratio	9.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	37.50
Previous Close	37.50
Day's Range	37.50 - 39.36
52-Week Range	29.70 - 59.00
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Chandra Bhagat Pharma

Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1944
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 542934

Financial Performance

In fiscal year 2026, Chandra Bhagat Pharma's revenue was 1.16 billion, an increase of 30.99% compared to the previous year's 887.67 million. Earnings were 30.46 million, an increase of 255.11%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 5, 2026

Data Sources Report a data error